@bastrooms's missed testosterone dose concerns, fact-checked
Quick answer
Testosterone therapy in transmasculine individuals produces laryngeal growth and permanent vocal fold changes, with fundamental frequency typically declining within weeks of initiation and continuing to shift over the first twelve months. Individual variation in timing, degree of change, and duration of vocal instability is high, and outcomes are influenced by baseline anatomy, dosing, and age at initiation. Voice change is generally considered irreversible, distinguishing it from most other masculinizing effects of testosterone.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @bastrooms actually say?
Benji posted a voice progression video tracking changes from pre-testosterone through one year of HRT, hitting timestamps at one week, two weeks, three weeks, one month, six weeks, seven weeks, two months, three through nine months, eleven months, and one year. Notably absent: month ten, which the caption acknowledges with a simple "Missed month 10." The video makes no explicit medical claims. It is a personal documentation, not advice. That said, 578,000 views means a lot of people are drawing conclusions from it, so the implicit claim, that this timeline is representative of how testosterone affects the voice, deserves scrutiny.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @bastrooms's missed testosterone dose concerns, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@bastrooms's missed testosterone dose concerns, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone therapy in transmasculine individuals produces laryngeal growth and permanent vocal fold changes, with fundamental frequency typically declining within weeks of initiation and continuing to shift over the first twelve months.
FormBlends verdict
Testosterone therapy in transmasculine individuals produces laryngeal growth and permanent vocal fold changes, with fundamental frequency typically declining within weeks of initiation and continuing to shift over the first twelve months. Individual variation in timing, degree of change, and duration of vocal instability is high, and outcomes are influenced by baseline anatomy, dosing, and age at initiation. Voice change is generally considered irreversible, distinguishing it from most other masculinizing effects of testosterone.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone therapy in transmasculine individuals produces laryngeal growth and permanent vocal fold changes, with fundamental frequency typically declining within weeks of initiation and continuing to shift over the first twelve months. Individual variation in timing, degree of change, and duration of vocal instability is high, and outcomes are influenced by baseline anatomy, dosing, and age at initiation. Voice change is generally considered irreversible, distinguishing it from most other masculinizing effects of testosterone.
- Testosterone-induced voice changes are driven by laryngeal growth and are considered permanent and irreversible, unlike most other HRT effects.
- Azul et al. (2017, Journal of Voice) found significant individual variation in the rate and degree of vocal change during the first year of testosterone therapy.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Testosterone-induced voice changes are driven by laryngeal growth and are considered permanent and irreversible, unlike most other HRT effects.
- Azul et al. (2017, Journal of Voice) found significant individual variation in the rate and degree of vocal change during the first year of testosterone therapy.
- Fundamental frequency typically begins declining within weeks to months of testosterone initiation, but the exact timeline differs substantially between individuals.
- Vocal instability, including cracking and inconsistency, is a documented phase and not a sign that therapy is not working.
- Yeung et al. (2020, Otolaryngology: Head and Neck Surgery) identified baseline anatomy, age, and dosing protocol as key variables in predicting voice outcomes.
- Speech-language pathologists specializing in transgender voice can reduce strain risk and support vocal health during the change period.
- No single progression video, regardless of view count, is a reliable predictor of any individual's voice change timeline or outcome.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Benji · TikTok creator
578.4K views on this video
Missed month 10😔 #fyp #fy #lgbtq #trans #ftm #transman #afab #transgender #transmasc #testosterone #hrt
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Benji, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.